Overview

ISO 14937:2009 - Sterilization of health care products - defines general requirements for characterizing a sterilizing agent and for the development, validation and routine control of sterilization processes for medical devices. It applies to processes that inactivate microorganisms by physical and/or chemical means and specifies the essential elements of a Quality Management System (QMS) needed to ensure reproducible sterilization performance. Target users include process developers, sterilizer manufacturers, medical device producers and organizations performing sterilization.

Key topics and technical requirements

ISO 14937:2009 structures the lifecycle of a sterilization process into clear, auditable elements:

QMS elements: documentation, management responsibility, product realization, measurement/analysis and control of non-conforming product.
Sterilizing agent characterization: description of the agent, microbicidal effectiveness, material compatibility, safety and environmental considerations.
Process and equipment characterization: process mapping, equipment capabilities and limits, and critical process parameters.
Product and process definition: defining product families, bioburden considerations and process acceptance criteria.
Validation: staged qualification including Installation Qualification (IQ), Operational Qualification (OQ) and Performance Qualification (PQ).
Routine monitoring and control: in-process controls, indicators, product release criteria and record keeping.
Maintaining effectiveness: calibration, maintenance, requalification and change assessment.
Annexes provide normative guidance - selection of challenge microorganisms, three approaches for process definition (based on natural bioburden, reference organisms, or conservative reference-based definitions) and informative application guidance.

These requirements are intended to deliver a sterilization process that is reproducible, reliable and auditable, enabling assessment of sterility in probabilistic terms rather than absolute guarantees.

Applications and who uses it

ISO 14937:2009 is used for:

Developing new sterilization methods where no specific standard exists (e.g., novel chemical agents or proprietary cycles).
Validating and controlling sterilization lines in medical device manufacturing and contract sterilization facilities.
Guiding sterilizer equipment manufacturers in characterizing performance and designing validation support.
Regulatory and quality teams establishing procedures for product release, routine monitoring and change control.

Practical benefits include improved process robustness, defensible validation packages, and alignment with regulatory expectations for sterility assurance.

Related standards

ISO 13485 (medical device QMS)
ISO 17664 (processing of medical devices)
EN 556-1 and ANSI/AAMI ST67 (sterility requirements / SAL guidance)

Keywords: ISO 14937:2009, sterilization process validation, sterilizing agent characterization, medical device sterilization, IQ OQ PQ, routine monitoring, bioburden, quality management system.

Overview

Key topics and technical requirements

ISO 14937:2009 structures the lifecycle of a sterilization process into clear, auditable elements:

QMS elements: documentation, management responsibility, product realization, measurement/analysis and control of non-conforming product.
Sterilizing agent characterization: description of the agent, microbicidal effectiveness, material compatibility, safety and environmental considerations.
Process and equipment characterization: process mapping, equipment capabilities and limits, and critical process parameters.
Product and process definition: defining product families, bioburden considerations and process acceptance criteria.
Validation: staged qualification including Installation Qualification (IQ), Operational Qualification (OQ) and Performance Qualification (PQ).
Routine monitoring and control: in-process controls, indicators, product release criteria and record keeping.
Maintaining effectiveness: calibration, maintenance, requalification and change assessment.
Annexes provide normative guidance - selection of challenge microorganisms, three approaches for process definition (based on natural bioburden, reference organisms, or conservative reference-based definitions) and informative application guidance.

Applications and who uses it

ISO 14937:2009 is used for:

Developing new sterilization methods where no specific standard exists (e.g., novel chemical agents or proprietary cycles).
Validating and controlling sterilization lines in medical device manufacturing and contract sterilization facilities.
Guiding sterilizer equipment manufacturers in characterizing performance and designing validation support.
Regulatory and quality teams establishing procedures for product release, routine monitoring and change control.

Practical benefits include improved process robustness, defensible validation packages, and alignment with regulatory expectations for sterility assurance.

Related standards

ISO 13485 (medical device QMS)
ISO 17664 (processing of medical devices)
EN 556-1 and ANSI/AAMI ST67 (sterility requirements / SAL guidance)

Keywords: ISO 14937:2009, sterilization process validation, sterilizing agent characterization, medical device sterilization, IQ OQ PQ, routine monitoring, bioburden, quality management system.

ISO 14937:2009 PDF

Technical details

Abstract

Overview

Key topics and technical requirements

Applications and who uses it

Related standards

Related standards

Abstract

Overview

Key topics and technical requirements

Applications and who uses it

Related standards

Related standards

Medical devices - Quality management systems - Requirements for regulatory purposes (ISO 13485:2016)

Processing of health care products - Information to be provided by the medical device manufacturer for the pr…

Systems and software engineering — Software life cycle processes

Asset management — Vocabulary, overview and principles

Asset management — Asset management system — Requirements

Information technology — Radio frequency identification device conformance test methods — Part 2: Test method…

Information technology — Multimedia framework (MPEG-21) — Part 22: User Description

Milk — Determination of the lactoperoxidase activity — Photometric method (Reference method)